CUTANEOUS T CELL LYMPHOMAS (CTCL)

Clinical trials for CUTANEOUS T CELL LYMPHOMAS (CTCL) explained in plain language.

Never miss a new study

Get alerted when new CUTANEOUS T CELL LYMPHOMAS (CTCL) trials appear

Sign up with your email to follow new studies for CUTANEOUS T CELL LYMPHOMAS (CTCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Pioneering trial tests 'Off-the-Shelf' bone marrow from deceased donors

Disease control Recruiting now

This early-stage study is testing the safety and feasibility of using bone marrow from deceased donors for patients with various blood cancers like leukemia and lymphoma. The goal is to see if this type of transplant can help patients when a living donor isn't available. Research…

Matched conditions: CUTANEOUS T CELL LYMPHOMAS (CTCL)

Phase: PHASE1, PHASE2 • Sponsor: Ossium Health, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

CUTANEOUS T CELL LYMPHOMAS (CTCL)

Get alerted when new CUTANEOUS T CELL LYMPHOMAS (CTCL) trials appear

Pioneering trial tests 'Off-the-Shelf' bone marrow from deceased donors